NCT03451487View on ClinicalTrials.gov

A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study

NACompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

May 19, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Acetaminophen Toxicity

Interventions

DRUG

Panadol®

Acetaminophen 500mg Tablet

DRUG

SafeTynadol®

Acetaminophen 500mg Tablet

Trial Locations (1)

114202

Tri-Service General Hospital, Taipei

All Listed Sponsors

lead

Sinew Pharma Inc.

INDUSTRY